Frequency of cervical epithelial lesions reported in the Regional Laboratory of Exfoliative Cytology in Jalisco
Main Article Content
Keywords
Screening, Cytology, Cervical intraepithelial neoplasia, Mexico
Abstract
Background: The Official Mexican Norm for the prevention, treatment and control of Cervical Cancer (CC) indicates that the Papanicolau (Pap) is the procedure for the detection of this neoplasia; therefore, it is of interest to know the prevalence of suspected cases by this technique in Mexican population. In this study, we show the diagnosed cases in the State of Jalisco, México.
Methods: A retrospective study was made to the samples that arrived for their analysis to the Laboratorio Regional de Citología Exfoliativa (LARCE), of the Instituto Mexicano del Seguro Social (IMSS) in Guadalajara, Jalisco. We considered all cases from January 2010 to December 2012.
Results: We analyzed 188 095 cases, from which 5.3 % had a diagnosis of low dysplasia, 0.18 % of moderated dysplasia and 0.05 % of high dysplasia. Microinvasive and invasive cancer showed a low frequency (0.03 %).
Conclusions: The frequency of abnormal findings identified by vaginal cervical cytology is relatively low. The number of inadequate and limited samples for cytological assessment is high; there is a high proportion of women attending for the first time in life to cytology evaluation in older age groups.
References
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-917, doi:10.1002/ijc.25516
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90, doi:caac.20107 [pii]10.3322/caac.20107
Sosa-Rubi SG, Walker D, Servan E. [Performance of mammography and Papanicolaou among rural women in Mexico]. Salud Publica Mex. 2009;51 Suppl 2, s236-45. doi:S0036-36342009000800014 [pii]
Flannelly G. The management of women with abnormal cervical cytology in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2010;24,51-60, doi:S1521-6934(09)00101-1 [pii]10.1016/j.bpobgyn.2009.07.001
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-9. doi:10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F [pii]10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
Kahn JA. HPV vaccination for the prevention of cervical intraepithelial neoplasia. N Engl J Med. 2009;361:271-8. doi:361/3/271 [pii]10.1056/NEJMct0806938
Di Saia PJ, Creasman WT. Clinical Gynecologic Oncology. 8th ed., Philadelphia PA, USA: Saunders Elsevier; 2012.
Berek JS, Hacker NF. Berek & Hacker’s Gynecologic Oncology. 5th ed., Philadelphia, PA, USA: Wolters Kluwer/Lippincott Williams & Wilkins Health; 2010.
Jayshree RS, Sreenivas A, Tessy M, Krishna S. Cell intrinsic & extrinsic factors in cervical carcinogenesis. Indian J Med Res. 2009;130:286-95.
Oxorn H. Cervical cytology; key to diagnosis of early uterine cancer. Surg Gynecol Obstet. 1948;87:197-205.
Koss LG. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA. 1989;261:737-43.
Gutierrez-Trujillo G, Martínez-Montañez OG, Fernández-Gárate IH, Mejía-Rodríguez I, Alvarado I, Reyes-Morales H. [Analysis of the decrease in mortality due to cervical cancer at the Mexican Institute of Social Security, from 1991 to 2005]. Rev Med Inst Mex Seguro Soc. 2006;44 Suppl:S129-34.
Cannistra SA, Niloff JM. Cancer of the uterine cervix. N Engl J Med. 1996;334:1030-8. doi:10.1056/NEJM199604183341606
Vesco KK, Whitlock EP, Eder M, Burda BU, Senger CA, Lutz KW. Risk factors and other epidemiologic considerations for cervical cancer screening: a narrative review for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155:698-705. W216, doi:0003-4819-155-10-201111150-00377 [pii]10.7326/0003-4819-155-10-201111150-00377
Kalliala I, Dyba T, Nieminen P, Hakulinen T, Anttila A. Mortality in a long-term follow-up after treatment of CIN. Int J Cancer. 2010;126:224-31. doi:10.1002/ijc.24713
Shingleton HM, Patrick RL, Johnston WW, Smith RA. The current status of the Papanicolaou smear. CA Cancer J Clin. 1995;45:305-20.
Hernandez-Hernandez DM, Linaldi-Yepez F, Apresa-García T, Escudero-de los Ríos P, Alvarado-Cabrero LA, Ornelas-Bernal A, et al. [Associated factors for women’s non-compliance for cervical cancer screening]. Rev Med Inst Mex Seguro Soc. 2007;45:313-20.
Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ. 2001;79:954-62. doi:S0042-96862001001000009 [pii]
Hidalgo-Martínez AC. El cáncer cérvico-uterino, su impacto en México y el porqué no funciona el programa nacional de detección oportuna. Rev Biomed. 2006;17:81-4.
Lazcano-Ponce EC, Nájera-Aguilar P, Buiatti E, Alonso-de Ruiz P, Kuri P, Cantoral L, et al. The cervical cancer screening program in Mexico: problems with access and coverage. Cancer Causes Control. 1997;8(5):698-704.
Cuzick, J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P. Human papillomavirus testing in primary cervical screening. Lancet. 1995;345:1533-6.
McCrory DC, Matchar DB, Bastian L, Datta S, Hasselblad V, Hickey J, et al. Evaluation of cervical cytology. Evid Rep Technol Assess (Summ). 1999;(5):1-6.
Donoso E, Cuello M, Villarroel PL. Reducción de la Mortalidad por Cáncer Cérvico Uterino en Chile, 1990-2003. Rev Chil Obstet Ginecol. 2006;71:307-12.
Valderrama M, Campos F, Cárcamo C, García P. Factores Asociados a lesiones cervicales o presencia del virus del papiloma humano en dos poblaciones de estudiantes de Lima. Rev Peru Med Exp Salud Publica. 2007;24:234-9.
Ulate-Arguedas H, Alfaro-Pacheco R. Incidencia de citologías cervicales alteradas en mujeres menores de 20 años, en el área de salud de Paso Ancho - San Sebastian entre el 2006 y el 2010. Revista Médica de Costa Rica y Centroamérica. 2011;LXVIII,596:127-31.
Vizcaino AP, Moreno V, Bosch FX, Muñoz M, Barros-Dios XM, Borras J. International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer. 2000;86:429-35. doi:10.1002/(SICI)1097-0215(20000501)86:3<429::AID-IJC20>3.0.CO;2-D [pii]
Parkin DM, Ferlay J, Curado MP, Bray F, Edwards B, Shin HR, et al. Fifty years of cancer incidence: CI5 I-IX. Int J Cancer. 2010;127:2918-27. doi:10.1002/ijc.25517 (2010).